Here are the Top 6 Pharma Journalists that Focus on Health Equity
Building mutually beneficial relationships with key journalists requires the ability to measure influence at a granular (or topical) level. Utilizing Reputos, our influencer advocacy tool, StratInt Research developed a list of the top six pharma journalists on health equity, grouping authors into two buckets based on audience size (10K-100K followers and 1K-10K followers). In addition […]
Senate HELP Committee Hearing on Moderna Vaccine Pricing: Defining and Scoring Participants in the Social Conversation
Members of the Senate Committee on Health, Education, Labor, and Pensions (HELP) questioned Moderna CEO Stephane Bancel on Wednesday, March 22 about the company’s plan to increase the price of its COVID-19 vaccine. As is typical of pharma hearings, Bancel’s testimony generated numerous attention-grabbing headlines in traditional media from a variety of high-profile sources: “Democrats […]
Journalists on FDA Approvals: Building a Proactive Engagement Strategy for A Marketing Campaign
Following years of R&D investment in a medicine, an FDA approval is a major financial victory for a drug maker. Without one, a pharmaceutical company cannot market a drug with medical claims. Accordingly, an approval is the ideal opportunity for a company’s communications team to execute on a carefully crafted media engagement strategy that results […]
Senate Finance Committee on Corporate Taxes: Identifying the Influential Voices on Social Media
Big Pharma’s tax practices are the subject of a multiyear investigation by the Senate Finance Committee, with lawmakers targeting Merck, Bristol Myers Squibb, AbbVie, Abbott, and Amgen for financial details. The hot-button issue of taxes is reputationally risky for any corporation but the nexus between the pharmaceutical industry’s tax practices and drug prices, a topic […]
